Incanthera
Goal Group
  • About us
    • What we do
    • Our strategy
    • Market opportunity
    • Our team
    • Our History
    • Origins – Institute of Cancer Therapeutics (ICT) Bradford
  • Pipeline
    • Our products
    • For patients
  • Partnering
    • Our partnerships
  • Investors
    • Overview
    • Why invest?
    • IPO materials
    • Regulatory news
    • Results, Reports and Presentations
    • Research Notes
    • Email alerts
    • Share price and tools
    • Financial calendar
    • Shareholder information
    • Investor and Advisor contacts
    • AQSE Growth Market Rule 4.14
    • Corporate Governance
    • Company Contact Details
  • News & media
    • News
    • Press Coverage
    • Scientific Publications
  • Contact Us
  • Sustainability
Share price INC 05.75 GBp
  • About us
    • What we do
    • Our strategy
    • Market opportunity
    • Our team
      • Board of Directors
      • Senior Management
      • Advisors and Founders
    • Our History
    • Origins – Institute of Cancer Therapeutics (ICT) Bradford
  • Pipeline
    • Our products
    • For patients
  • Partnering
    • Our partnerships
  • Investors
    • Overview
    • Why invest?
    • IPO materials
    • Regulatory news
    • Results, Reports and Presentations
    • Research Notes
    • Email alerts
    • Share price and tools
      • Share price chart
      • Detailed share price
    • Financial calendar
    • Shareholder information
      • Shareholder Information
      • AGM
      • GM
      • Analyst coverage
    • Investor and Advisor contacts
    • AQSE Growth Market Rule 4.14
    • Corporate Governance
      • Corporate Governance Report
      • QCA Corporate Governance Principles
    • Company Contact Details
  • News & media
    • News
    • Press Coverage
    • Scientific Publications
  • Contact Us
  • Sustainability

News

  • Home
  • News & media
  • News
  • News
  • Press Coverage
  • Scientific Publications

Latest from Incanthera

News

  • 2025
  • 2024
  • 2023
  • Archive
June 12th, 2024 Incanthera chairman discusses new director, strategic fundraising and Aquis promotion
  • View full post
June 10th, 2024 Incanthera plc Appointment Senior Independent Director, Promotion to Apex
  • Download PDF
June 4th, 2024 AQSE Webinar Presentation 'Aquis Leading Lights: Meet the Company of the Year 2024 Nominees’
  • Download PDF
June 3rd, 2024 Skin + CELL First Production Order Doubled Again Institutional Investor-led Subscription and Sale Shares Totalling £4.1 million Posting of Circular of General Meeting
May 16th, 2024 Investor Presentation
  • Download the Presentation
April 23rd, 2024 Confirmation of Warrants Conclusion
  • Prev
  • 1
  • 2
  • 3
  • Next
  • Incanthera
  • Incanthera
  • Incanthera
  • Incanthera
  • Incanthera
  • Incanthera
Sign up for email alerts Register your email

This website uses cookies. By continuing to access the site you are agreeing to their use. Learn more about cookies.

  • © 2025 Incanthera plc

  • Sitemap
  • Contact Us
  • Privacy Policy

By  emperor